TY - JOUR
T1 - Transactive response DNA-binding protein-43 proteinopathy in oligodendrocytes revealed using an induced pluripotent stem cell model
AU - Barton, Samantha K.
AU - Gregory, Jenna
AU - Magnani, Dario
AU - James, Owen G.
AU - Livesey, Matthew R.
AU - Selvaraj, Bhuvaneish T.
AU - James, Owain T.
AU - Perkins, Emma M.
AU - Cleary, Elaine M.
AU - Ausems, C Rosanne M
AU - Carter, Roderick N.
AU - Vasistha, Navneet A.
AU - Zhao, Chen-Ru
AU - Burr, Karen
AU - Story, David
AU - Cardinali, Alessandra
AU - Morton, Nicholas M.
AU - Hardingham, Giles E.
AU - Wyllie, David J. A.
AU - Chandran, Siddharthan
N1 - Acknowledgements
The authors kindly acknowledge the technical expertise and
assistance of Ms Nicola Miller and Ms Karen Gladstone.
Graphical abstract was created using BioRender.com.
Funding
This research was supported by the Wellcome Trust
(092742/Z/10/Z), MND Association (Miles/Oct14/878–
792), SC lab is supported by the Euan MacDonald Centre
for Motor Neurone Disease Research, and the UK Dementia
Research Institute (DRI), which receives its funding from UK
DRI Ltd, funded by the MRC, Alzheimer’s Society and
Alzheimer’s Research UK. SC also acknowledges funding
from the ARRNC, Department of Biotechnology India,
University of Edinburgh Institutional Strategic Support Fund.
Royal Society of Edinburgh (M.R.L), WT NIA 100981/Z/
13/Z (N.M.M.), ARRNC (B.T.S) and an Australian
National Health and Medical Research (NH&MRC) and
Australian Research Council (ARC) Dementia Research
Development Fellowship (S.K.B.: 1110040)
PY - 2021
Y1 - 2021
N2 - Oligodendrocytes are implicated in amyotrophic lateral sclerosis pathogenesis and display transactive response DNA-binding protein-43 (TDP-43) pathological inclusions. To investigate the cell autonomous consequences of TDP-43 mutations on human oligodendrocytes, we generated oligodendrocytes from patient-derived induced pluripotent stem cell lines harbouring mutations in the TARDBP gene, namely G298S and M337V. Through a combination of immunocytochemistry, electrophysiological assessment via whole-cell patch clamping, and three-dimensional cultures, no differences in oligodendrocyte differentiation, maturation or myelination were identified. Furthermore, expression analysis for monocarboxylate transporter 1 (a lactate transporter) coupled with a glycolytic stress test showed no deficit in lactate export. However, using confocal microscopy, we report TDP-43 mutation-dependent pathological mis-accumulation of TDP-43. Furthermore, using in vitro patch-clamp recordings, we identified functional Ca2þpermeable a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor dysregulation in oligodendrocytes. Together, these findings establish a platform for further interrogation of the role of oligodendrocytes and cellular autonomy in TDP-43 proteinopathy.
AB - Oligodendrocytes are implicated in amyotrophic lateral sclerosis pathogenesis and display transactive response DNA-binding protein-43 (TDP-43) pathological inclusions. To investigate the cell autonomous consequences of TDP-43 mutations on human oligodendrocytes, we generated oligodendrocytes from patient-derived induced pluripotent stem cell lines harbouring mutations in the TARDBP gene, namely G298S and M337V. Through a combination of immunocytochemistry, electrophysiological assessment via whole-cell patch clamping, and three-dimensional cultures, no differences in oligodendrocyte differentiation, maturation or myelination were identified. Furthermore, expression analysis for monocarboxylate transporter 1 (a lactate transporter) coupled with a glycolytic stress test showed no deficit in lactate export. However, using confocal microscopy, we report TDP-43 mutation-dependent pathological mis-accumulation of TDP-43. Furthermore, using in vitro patch-clamp recordings, we identified functional Ca2þpermeable a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor dysregulation in oligodendrocytes. Together, these findings establish a platform for further interrogation of the role of oligodendrocytes and cellular autonomy in TDP-43 proteinopathy.
KW - amyotrophic lateral sclerosis
KW - oligodendrocytes
KW - TDP-43
KW - induced pluripotent stem cell
UR - http://dx.doi.org/10.1093/braincomms/fcab255
U2 - 10.1093/braincomms/fcab255
DO - 10.1093/braincomms/fcab255
M3 - Article
VL - 3
JO - Brain Communications
JF - Brain Communications
SN - 2632-1297
IS - 4
M1 - fcab255
ER -